This is a Validated Antibody Database (VAD) review about mouse Arpc3, based on 6 published articles (read how Labome selects the articles), using Arpc3 antibody in all methods. It is aimed to help Labome visitors find the most suited Arpc3 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Arpc3 synonym: 1110006A04Rik; p21-ARC; p21-Ar; p21Arc

Santa Cruz Biotechnology
mouse monoclonal (E-7)
  • western blot; mouse; 1:200; loading ...; fig 2b
Santa Cruz Biotechnology Arpc3 antibody (Santa Cruz, sc-166630) was used in western blot on mouse samples at 1:200 (fig 2b). Adv Sci (Weinh) (2022) ncbi
mouse monoclonal (E-7)
  • western blot; mouse; 1:1000; loading ...; fig 5a
Santa Cruz Biotechnology Arpc3 antibody (Santa Cruz Biotechnology, sc-166630) was used in western blot on mouse samples at 1:1000 (fig 5a). Int J Oral Sci (2021) ncbi
mouse monoclonal (26)
  • western blot; human; 1:200; loading ...; fig 6c
Santa Cruz Biotechnology Arpc3 antibody (Santa Cruz Biotechnology, sc-136020) was used in western blot on human samples at 1:200 (fig 6c). Nat Med (2016) ncbi
BD Biosciences
mouse monoclonal (26/p21-Arc)
  • western blot; human; 1:200; loading ...; fig 7d
BD Biosciences Arpc3 antibody (BD Biosciences, 612234) was used in western blot on human samples at 1:200 (fig 7d). Nat Commun (2021) ncbi
mouse monoclonal (26/p21-Arc)
  • western blot; human; 1:1000; loading ...; fig 1c
BD Biosciences Arpc3 antibody (BD Transduction lab, 612234) was used in western blot on human samples at 1:1000 (fig 1c). Nat Cell Biol (2016) ncbi
mouse monoclonal (26/p21-Arc)
  • immunocytochemistry; human; fig 2, 3, 4
BD Biosciences Arpc3 antibody (BD Biosciences, 612234) was used in immunocytochemistry on human samples (fig 2, 3, 4). Cardiovasc Res (2014) ncbi
Articles Reviewed
  1. Kumar D, Das M, Oberg A, Sahoo D, Wu P, Sauceda C, et al. Hepatocyte Deletion of IGF2 Prevents DNA Damage and Tumor Formation in Hepatocellular Carcinoma. Adv Sci (Weinh). 2022;9:e2105120 pubmed publisher
  2. Fayad R, Rojas M, Partisani M, Finetti P, Dib S, Abélanet S, et al. EFA6B regulates a stop signal for collective invasion in breast cancer. Nat Commun. 2021;12:2198 pubmed publisher
  3. Wang Q, Nie L, Zhao P, Zhou X, Ding Y, Chen Q, et al. Diabetes fuels periodontal lesions via GLUT1-driven macrophage inflammaging. Int J Oral Sci. 2021;13:11 pubmed publisher
  4. Frentzas S, Simoneau E, Bridgeman V, Vermeulen P, Foo S, Kostaras E, et al. Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases. Nat Med. 2016;22:1294-1302 pubmed publisher
  5. Abella J, Galloni C, Pernier J, Barry D, Kjær S, Carlier M, et al. Isoform diversity in the Arp2/3 complex determines actin filament dynamics. Nat Cell Biol. 2016;18:76-86 pubmed publisher
  6. Menhofer M, Bartel D, Liebl J, Kubisch R, Busse J, Wagner E, et al. In vitro and in vivo characterization of the actin polymerizing compound chondramide as an angiogenic inhibitor. Cardiovasc Res. 2014;104:303-14 pubmed publisher